Kura Oncology Announces Acceptance of Two Abstracts for
– Presentations to highlight preclinical data supporting combination of FTIs with KRASG12C inhibitors and tyrosine
Globe Newswire15-03-2023, 04:41
Wood Mackenzie appoints new Chief Financial Officer 27-03-2023, 23:22